Roche Diagnostics plans Jafza headquarters for Middle East
30 Jan 2012
Roche Diagnostics, the diagnostic division of global healthcare major Roche, will set up its Middle East headquarters in the Jebel Ali Free Zone (Jafza) in the United Arab Emirates and commence operations next month.
The announcement was made on the sidelines of a healthcare exhibition and medical congress, Arab Health in Dubai, today.
Roche is the global market leader in in-vitro diagnostics, has been present in the Middle East region for more than 30 years. But this will be Roche Diagnostics' first facility in the Middle East.
Through a strong distributor network, Roche Diagnostics has a presence in 18 markets in the Middle East with a 20-25 per cent market share in all of these markets.
Roche Diagnostics is seeking to increase the quality of supply and strengthen relations with distributors and end customers by providing added support and information.
In the UAE, Roche Diagnostics has been distributing its products and services through Pharmatrade over the past 30 years.
